Phillip Mertz
Direttore/Membro del Consiglio presso ALPHA COGNITION INC.
Patrimonio netto: 621 632 $ in data 30/04/2024
Posizioni attive di Phillip Mertz
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ALPHA COGNITION INC. | Direttore/Membro del Consiglio | 22/03/2021 | - |
Storia della carriera di Phillip Mertz
Precedenti posizioni note di Phillip Mertz
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Alpha Cognition, Inc. /old/
 Alpha Cognition, Inc. /old/ Pharmaceuticals: MajorHealth Technology Alpha Cognition, Inc. engages in operation of a biopharmaceutical company focused on the development of novel therapies to treat diseases of the brain and spinal cord. It also provides research programs to find alternative ways of treating Alzheimer’s disease and Amyotrophic Lateral Sclerosis (ALS). The company is headquartered in Vancouver, Canada. | Direttore/Membro del Consiglio | - | - |
Formazione di Phillip Mertz
| Harvard University | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Canada | 3 |
| Stati Uniti | 2 |
Posizioni
| Director/Board Member | 3 |
| Founder | 1 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ALPHA COGNITION INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Alpha Cognition, Inc. /old/
Alpha Cognition, Inc. /old/ Pharmaceuticals: MajorHealth Technology Alpha Cognition, Inc. engages in operation of a biopharmaceutical company focused on the development of novel therapies to treat diseases of the brain and spinal cord. It also provides research programs to find alternative ways of treating Alzheimer’s disease and Amyotrophic Lateral Sclerosis (ALS). The company is headquartered in Vancouver, Canada. | Health Technology |
- Borsa valori
- Insiders
- Phillip Mertz
- Esperienza
